Episode 220: Panorama Study 2 year results with Dr. Charles Wykoff

Dr. Charles Wykoff of Retinal Consultants of Houston joins to discuss the recently presented 2 year results of Regeneron's Panorama study of anti-VEGF for moderately severe and severe nonproliferative diabetic retinopathy.

Financial Disclosures:

Dr. Sridhar: Consultant for Alcon, Alimera, Oxurion, and RegeneronDr. Wykoff: Relevant Disclosures: Consultant/Speaker/Research Funding from Allergan, Genentech, and Regeneron, Consultant and Research Funding from Allergan

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.